GABRG2 rs6478108: Understanding Your Genetic Variant
The rs6478108 variant is located within the GABRG2 gene, which plays a critical role in the function of inhibitory neurotransmitter receptors in the brain. Research has linked variations in this gene to a spectrum of seizure-related conditions and altered GABAergic signaling.
What each genotype means
Common genetic profile
This genotype represents the most frequently observed sequence at this location in many populations. Research into this specific variant is limited, and it is not considered a primary driver of clinical conditions on its own. As with any genetic information, this should be viewed as one small piece of a much larger biological picture.
This is the most common genotype observed across most global populations.
Common genetic profile
Carrying one copy of each allele is a common variation observed in many healthy individuals. There is no strong evidence to suggest that this specific combination significantly alters GABRG2 function or increases susceptibility to neurological conditions. You should discuss any specific health concerns with your healthcare provider rather than relying on this single genetic marker.
This heterozygous genotype is found at moderate frequencies in diverse populations worldwide.
Common genetic profile
This genotype is a standard variation found in the general population. While the GABRG2 gene is known to be involved in neurotransmission and epilepsy, this specific variant is not established as a significant risk factor for clinical disease. Genetic results like this do not provide a diagnosis and should be interpreted in the context of your overall health history.
This genotype is present in a significant portion of the population, though it is generally less common than the C/C genotype.
What is the rs6478108 Variant?
The rs6478108 variant is a single nucleotide polymorphism (SNP) located within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is cataloged in public databases as a common genetic marker. While many SNPs have no observable effect on health, researchers study variants in genes like GABRG2 to understand how subtle changes in our genetic code might influence neurological function. Because this variant is common, it is found in a significant portion of the general population across various ancestries. It is important to note that the presence of a common variant does not inherently imply a medical condition, as most common genetic variations are part of the natural diversity of the human genome.
The Role of the GABRG2 Gene
The GABRG2 gene provides instructions for creating the gamma-2 subunit of the GABA-A receptor. GABA-A receptors are essential components of the central nervous system, acting as the primary inhibitory neurotransmitter system in the brain. By allowing chloride ions to enter neurons, these receptors help dampen electrical activity, effectively acting as a 'brake' on the brain's signaling pathways. When the GABRG2 gene functions correctly, it ensures that these receptors are properly assembled and positioned at the synapse. Disruptions or variations in this gene can potentially alter the sensitivity or density of these receptors, which may influence how the brain regulates excitability. Because of this central role in maintaining the balance between excitation and inhibition, the gene is a frequent subject of study in neurological research.
Research and Evidence Strength
Scientific literature has established that pathogenic mutations in GABRG2 are associated with a wide spectrum of epilepsy syndromes, ranging from simple febrile seizures to more severe developmental and epileptic encephalopathies. However, it is crucial to distinguish between rare, highly penetrant pathogenic mutations and common variants like rs6478108. While the gene itself is strongly linked to seizure susceptibility, the evidence for rs6478108 specifically is considered moderate in the context of health predisposition. Current research focuses on how variations in this region might contribute to the heterogeneity of seizure phenotypes. Because the relationship between common variants and complex neurological traits is often influenced by many other genetic and environmental factors, the clinical significance of this specific SNP remains a subject of ongoing investigation rather than a definitive diagnostic marker.
Population Frequency
The rs6478108 variant is considered common, meaning it appears frequently across diverse human populations. Large-scale genomic databases, such as gnomAD, provide data on the frequency of this allele, showing that it is present at significant levels in many global ancestries. This high frequency is typical for many common SNPs that do not cause severe, rare diseases but may contribute to subtle differences in physiological traits. Because it is so widespread, it is likely that a large number of healthy individuals carry one or two copies of the variant allele without experiencing any neurological symptoms. This prevalence underscores the fact that common genetic variants are rarely the sole cause of complex health outcomes and usually interact with a broader genetic and environmental background.
What You Can Do With This Information
Information about common genetic variants like rs6478108 is primarily educational and intended to help you understand the landscape of your own genome. It is important to recognize that this information cannot be used to diagnose a medical condition or predict your personal health future. If you have concerns about your neurological health, seizure history, or family history of epilepsy, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your full clinical history, which is far more informative than any single genetic marker. If you are currently taking medication for a neurological condition, never make changes to your treatment plan based on genetic data without first discussing it with your clinician or pharmacist, as they are the only ones qualified to manage your care.
How common is this variant?
The rs6478108 variant is a common polymorphism found across diverse global populations, with the minor allele frequency typically ranging significantly depending on ancestral background.
Frequently asked questions
Does having the rs6478108 variant mean I will have seizures?
No. This variant is a common genetic marker and is not a diagnostic test for epilepsy. Most people who carry this variant do not have seizures, as complex conditions are influenced by many genetic and environmental factors.
Is GABRG2 related to epilepsy?
Yes, rare and specific pathogenic mutations in the GABRG2 gene are well-documented causes of various epilepsy syndromes. However, common variants like rs6478108 are distinct from these rare, high-impact mutations.
Should I get tested for this variant?
Genetic testing for common variants is generally not recommended for clinical decision-making. If you have medical concerns, consult a doctor who can evaluate your symptoms and family history.
Can I change my risk associated with this gene?
Genetic variants are inherited and cannot be changed. However, managing overall health through regular medical check-ups and discussing any neurological concerns with a professional is the best way to manage your health.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6478108?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.